Excluding the above-mentioned patients from China, this c.1338C>A; p.(Tyr446*) mutation was not reported in a large cumulative summary of the BARD1 PVs mutation spectrum identified from breast and ovarian cancer patients, with the entire BARD1 coding sequence sequenced [30]. This evidence concerns the gene BARD1 and ovarian cancer.